The Last Human at the FDA: AI on a Skeleton Crew

Event ID: PP1162879

Mon, Mar 16, 2026 | 3:00 PM - 4:00 PM

Venue: Topaz Ballroom 1-3 (The LINE)

View on Official SXSW

Summary

Historic workforce cuts at FDA, CDC, and NIH are gutting review desks and lab benches. Regulators now pin hopes on AI triage engines to keep drug approvals, inspections and outbreak models on track. With capacity math and pilot algorithms already in production, we'll discuss accountability when fewer humans oversee smarter tools. What’s the single most important question to tell if a regulatory AI is trustworthy or just a black box? Where do the FDA and CDC need outside expertise? How can orgs support, innovate or build partnerships without entanglement in ethical or bureaucratic red tape?

Contributors

Raw Event JSON

Large nested arrays are compacted for page readability. Full payload remains in dataset files.

Open JSON payload
{
  "id": "PP1162879",
  "track": "Health",
  "focus_area": null,
  "category": "Fireside Chat",
  "event_id": "PP1162879",
  "event_type": "panel",
  "format": "Fireside Chat",
  "genre": null,
  "subgenre": null,
  "name": "The Last Human at the FDA: AI on a Skeleton Crew",
  "presented_by": "Real Chemistry",
  "publish_at": "2026-02-03T15:22:00.000-06:00",
  "reservable": true,
  "reservable_id": "PP1162879",
  "reserved": false,
  "date": "2026-03-16",
  "end_time": "2026-03-16T11:00:00.000-05:00",
  "start_time": "2026-03-16T10:00:00.000-05:00",
  "message": null,
  "image": null,
  "credentials": [
    {
      "name": "Music Badge",
      "type": "music"
    },
    {
      "name": "Platinum Badge",
      "type": "platinum"
    },
    {
      "name": "Innovation Badge",
      "type": "innovation"
    },
    {
      "name": "Film & TV Badge",
      "type": "filmtv"
    }
  ],
  "contributors": [
    {
      "id": 80051,
      "company": "Real Chemistry",
      "credential_types": [
        "filmtv",
        "innovation",
        "music"
      ],
      "entity_id": 2241357,
      "name": "Leslie Isenegger",
      "speaker_types": [],
      "title": "Practice Leader, Corporate Pricing & Public Affairs",
      "image": {
        "alt_text": "Leslie Isenegger",
        "credit": null,
        "url": "https://images.sxsw.com/p5JRVvBJOSX1LH3wVC6YL-ZkjDc=/600x600/images.sxsw.com/48/f1923a80-415c-3563-7949-d448cb9e9abd/pcid-1630495"
      },
      "speaker_type": "Speaker",
      "details": "Leslie Isenegger brings two decades of communication experience specializing in the integration of corporate reputation and risk mitigation, public policy, and health economics. She builds communication platforms to establish corporate pricing principles, increase industry thought leadership, and prepare clients for pricing and market access challenges. Leslie has supported drug approvals, led coalition-building for health policy initiatives, and developed crisis communication protocols for healthcare companies.",
      "links": {},
      "type": "person"
    },
    {
      "id": 80049,
      "company": "PAREXEL",
      "credential_types": [
        "filmtv",
        "innovation",
        "music"
      ],
      "entity_id": 2241355,
      "name": "Tala Fakhouri",
      "speaker_types": [],
      "title": "VP, Regulatory Consulting: AI & Digital Policy, Real-World Research",
      "image": {
        "alt_text": "Tala Fakhouri",
        "credit": null,
        "url": "https://images.sxsw.com/Q-Km0RF8fVZfaB9wroplIMAPj50=/600x600/images.sxsw.com/48/202ebc65-e2c6-61c0-20fe-472de5b16bef/pcid-1630494"
      },
      "speaker_type": "Speaker",
      "details": "Dr. Fakhouri is a strategic leader with extensive experience in regulatory affairs, AI-driven drug development, real-world data analytics and digital health technology. She has demonstrated success in developing and interpreting complex regulatory landscapes, providing strategic regulatory guidance, and fostering collaborations between regulators, industry and global stakeholders. Dr. Fakhouri has successfully led high-impact teams and managed complex initiatives to optimize regulatory decision-making and de-risk technology use in drug development. Formerly, Dr. Fakhouri was Associate Director for Data Science and Artificial Intelligence in the Office of Medical Policy, Center for Drug Evaluation and Research (CDER) at the FDA.",
      "links": {},
      "type": "person"
    }
  ],
  "venue": {
    "accessible": false,
    "age_policy": null,
    "floor": "2",
    "id": "V1703",
    "indoor_outdoor": "INDOOR",
    "name": "Topaz Ballroom 1-3",
    "parent_id": "V1700",
    "parent_venue_name": "The LINE",
    "venue_entry_info": null,
    "formats": null,
    "location": {
      "address": "111 E Cesar Chavez St.",
      "lat_lon": [
        30.2626651,
        -97.7436224
      ],
      "city": "Austin",
      "postal_code": "78701",
      "state": "TX",
      "name": "The LINE"
    },
    "root": {
      "accessible": null,
      "age_policy": null,
      "floor": null,
      "id": "V1700",
      "indoor_outdoor": "INDOOR",
      "name": "The LINE",
      "parent_id": null,
      "parent_venue_name": null,
      "venue_entry_info": null,
      "formats": null
    },
    "events": "[omitted 5 venue events]"
  },
  "description": "Historic workforce cuts at FDA, CDC, and NIH are gutting review desks and lab benches. Regulators now pin hopes on AI triage engines to keep drug approvals, inspections and outbreak models on track. With capacity math and pilot algorithms already in production, we'll discuss accountability when fewer humans oversee smarter tools. What’s the single most important question to tell if a regulatory AI is trustworthy or just a black box? Where do the FDA and CDC need outside expertise? How can orgs support, innovate or build partnerships without entanglement in ethical or bureaucratic red tape?",
  "experience_level": "Advanced",
  "accessibility": [],
  "accessible_venue": false,
  "add_bcl_url": false,
  "add_slido": false,
  "age_policy": null,
  "american_sign_language": false,
  "apple_url": null,
  "audio_description": false,
  "caption_url": null,
  "closed_captioned": false,
  "cpe_credit": false,
  "has_subtitles": false,
  "hash_tags": [],
  "high_sensory_experience": false,
  "live": false,
  "long_description": "Historic workforce cuts at FDA, CDC, and NIH are gutting review desks and lab benches. Regulators now pin hopes on AI triage engines to keep drug approvals, inspections and outbreak models on track. With capacity math and pilot algorithms already in production, we'll discuss accountability when fewer humans oversee smarter tools. What’s the single most important question to tell if a regulatory AI is trustworthy or just a black box? Where do the FDA and CDC need outside expertise? How can orgs support, innovate or build partnerships without entanglement in ethical or bureaucratic red tape?",
  "meeting_url": null,
  "meeting_url_live": false,
  "mentorly_url": null,
  "mobile_audio_url": null,
  "open_captioned": false,
  "playlist_tag": null,
  "rebroadcast": false,
  "recommended_ids": [],
  "search_conversions": null,
  "short_program": false,
  "slido_url": null,
  "sort": "LAST HUMAN AT THE FDA: AI ON A SKELETON CREW",
  "source": "Official",
  "squad_up_url": null,
  "stream_embed": null,
  "stream_id": null,
  "stream_url": null,
  "strobe_warning": false,
  "subdiscipline": null,
  "summit": null,
  "summit_display_name": null,
  "tags": [],
  "talent_attending": null,
  "title_only": false,
  "track_display_name": "Health",
  "trailer_id": null,
  "trailer_url": null,
  "video_on_demand": null,
  "vimeo_id": null,
  "vod": false,
  "xr_project_type": null,
  "youtube_id": null,
  "related_sales_client": null
}